Evosep Biolabs ApS
CVR 44216701 · Private limited company (ApS) · Active · Low risk
Evosep Biolabs ApS is a Private limited company (ApS), founded on , based in Odense M. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 701k and a net result of DKK -4.0m. CEO: Morten Bern, Jens Bornhøft Christensen.
Bankruptcy risk for Evosep Biolabs ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44216701
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- Billedskærervej 15
5230 Odense M - Municipality
- Odense
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -3.6m | DKK -2.8m |
| Net profit | DKK -4.0m | DKK -2.9m |
| Equity | DKK 701k | DKK -2.9m |
| Total assets | DKK 701k | DKK 1.5m |
| Cash | DKK 330k | – |
| Short-term debt | DKK 0 | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Dansk Revision Odense.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 111 | ||
| 28 Jul 2023 – 31 Dec 2024 | 83 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Morten Bern | Current | |
| CEO | Jens Bornhøft Christensen | Current | |
| CEO | Ole Vorm | ||
| CEO | Christian Ravnsborg | ||
| Owner (100%) | Evosep ApS | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | DANSK REVISION ODENSE GODKENDT REVISIONSAKTIESELSKAB | ||
| Founder | Evosep ApS | Current |
The CEOs' other companies
Morten Bern – 4 other companies
- COLOURBOX ApS Active
- Ejendomsselskabet Johannelyst, Randers ApS Active
- Evosep ApS Active
- Morla Holding ApS Active
Jens Bornhøft Christensen – 3 other companies
- Bornhøft Capital ApS Active
- Evosep ApS Active
- OUTDOOR ENGINEERING ApS Opløst
Ole Vorm – 26 other companies, of which 2 bankrupt
- JAG EJENDOMME ApS Bankrupt 3 Nov 2010
- MDS PROTEOMICS A/S Bankrupt 2 Jun 2006
- CTEK A/S Fusioneret
- Cohop ApS Active
- EMT NORDIC A/S Fusioneret
- Evosep ApS Active
- Fida Biosystems ApS Active
- JES J. PETERSEN A/S Active
- JES J. PETERSEN PROPERTY INVESTMENT A/S Active
- MARIENLYST PALÆET ApS Opløst
- MDS PROTEOMICS 2 A/S Opløst
- OLE VORM HOLDING ApS Active
- OmicVision Biosciences ApS Active
- PROXEON A/S Fusioneret
- PROXEON BIOINFORMATICS A/S Fusioneret
- PROXEON BIOSYSTEMS ApS Active
- PROXIMUS A/S Active
- PROXIMUS PROJECT A/S Active
- Paradigm TopCo ApS Active
- SV PARKERING ApS Opløst
- SYDDANSK INNOVATION ApS Opløst
- SpInl Invest 3 ApS Active
- SpInl Invest ApS Active
- Spectro Inlets ApS Active
- VM-LEASING A/S Active
- VOMA HOLDING A/S Active
Address history (1 moves)
| Billedskærervej 15, 5230 Odense M | |
| Buchwaldsgade 35, 3., 5000 Odense C |
Other companies at the same address
- DISTRIBUTION FYN ApS Bankrupt
- Evosep ApS Active
- Paradigm BidCo ApS Active
- Paradigm MidCo 2 ApS Active
- Paradigm TopCo ApS Active
Similar companies in Odense
- Inverna Therapeutics ApS Odense M
- Uvigga Technologies ApS Odense C
- B Proteomics ApS Odense M
- Nordic microbes A/S Odense C
- Algiecel A/S Odense M
- QNTM Labs ApS Odense SØ
- Evosep ApS Odense M
- CELVIVO ApS Odense SØ
- Ovodan Biotech A/S Odense C
- MARTECH ApS Odense C
- HOUSETEST ApS Odense C
- Ranger Biotechnologies A/S Odense SØ
Questions and answers about Evosep Biolabs ApS
Has Evosep Biolabs ApS gone bankrupt?
No, Evosep Biolabs ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Evosep Biolabs ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Evosep Biolabs ApS?
Morten Bern, Jens Bornhøft Christensen are the CEOs of Evosep Biolabs ApS.
Who is the auditor of Evosep Biolabs ApS?
Evosep Biolabs ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Evosep Biolabs ApS founded?
Evosep Biolabs ApS was founded on 28 July 2023.
What is the equity of Evosep Biolabs ApS?
Equity was DKK 701k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.